Alaunos Therapeutics, Inc. (TCRT) Stock Price & Analysis
Alaunos Therapeutics, Inc. (TCRT) closed at USD 2.18 on Thursday, October 15, 2026, up 5.31% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 2.07; the Oct 15, 2026 session ranged USD 1.8–2.39 on volume of 12,982,953 shares. Market capitalization is $6.38M, with a 52-week range of USD 0.72–4.5 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:11 UTC.
Also available as compact Markdown for AI agents: nexqual.com/TCRT.md
Key facts (TCRT)
- Analysts: None.
- Total return with dividends: 1Y -29.7% vs S&P 500 +18.1%; 5Y -99.1% vs S&P 500 +85.1%.
Analysts (TCRT)
Consensus None.
Total return (dividends reinvested) (TCRT)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -29.7% | -99.1% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -29.8% | -61.3% |
| Volatility (annualized) | 143.3% | 128.1% |
| Max drawdown | -83.0% (Dec 2025→Oct 2026) | -99.9% (Sep 2022→Oct 2026) |
Key Statistics (as of October 16, 2026 at 05:11 UTC)
| Price | USD 2.18 |
|---|---|
| Change | ▲ 5.31% (up) |
| Previous Close | USD 2.07 |
| Open | USD 2.09 |
| Day Range | USD 1.8 – 2.39 |
| 52-Week Range | USD 0.72 – 4.5 |
| Volume | 12,982,953 shares |
| Market Cap | $6.38M |
| Exchange | NCM |
Technical Analysis (TCRT)
Nexqual's technical model rates TCRT "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 16, 2026 at 05:11 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 61.91 (neutral) |
| vs SMA50 | Above (USD 1.52) |
| MACD | 0.11 (positive) |
Analyst Ratings (TCRT)
Wall Street analysts rate TCRT "None", per Nexqual as of October 16, 2026 at 05:11 UTC.
| Consensus Rating | None |
|---|
Earnings (TCRT)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2023-12-31 | USD -17.09 vs est -4.5 ▼ miss |
| 2023-09-30 | USD -4.41 vs est -5.25 ▲ beat |
| 2023-06-30 | USD -6 vs est -6.75 ▲ beat |
| 2023-03-31 | USD -6 vs est -6.6 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Financials & Fundamentals (TCRT)
| Total Revenue | $3,000 |
|---|---|
| Gross Margin | +0.00% |
| Operating Margin | -135233.33% |
| Profit Margin | +0.00% |
| ROE | -185.95% |
| Current Ratio | 0.77 |
| Total Cash | $124,000 |
| Total Debt | $0 |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Financial Health Score (TCRT)
Nexqual rates Alaunos Therapeutics, Inc.'s overall financial health "Weak" across five dimensions, as of October 16, 2026 at 05:11 UTC.
| Growth | Critical — Revenue -100% YoY (annual), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $124K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$3M (TTM) |
| Efficiency | Critical — ROE -186%, ROA -81.1% |
Ownership (TCRT)
| Insider Ownership | +16.32% |
|---|---|
| Institutional Ownership | +4.23% |
| Shares Outstanding | 2.93M |
| Float | 1.89M |
| Short % of Float | +0.36% |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Major Backers & Investors (TCRT)
Notable institutional backers of Alaunos Therapeutics, Inc. include Fidelity, Citadel, according to Nexqual as of October 16, 2026 at 05:11 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.7% |
| Citadel | 0.47% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.71% |
| BlackRock | 0.84% |
| Geode Capital | 0.76% |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals, Inc. | USD 87.97 | ▲ 1.57% |
| BLTE | Belite Bio, Inc | USD 152.62 | ▲ 0.49% |
| IOVA | Iovance Biotherapeutics, Inc. | USD 14.72 | ▲ 1.52% |
| PRAX | Praxis Precision Medicines, Inc | USD 248.24 | ▲ 2.01% |
| IONS | Ionis Pharmaceuticals, Inc. | USD 44.12 | ▲ 4.11% |
| SYRE | Spyre Therapeutics, Inc. | USD 80.1 | ▼ 0.44% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:11 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt